Discovery of novel A2AR antagonists through deep learning-based virtual screening
The A2A adenosine receptor (A2AR) is emerging as a promising drug target for cancer immunotherapy. Novel A2AR antagonists are highly demanded due to few candidates entering clinic trials specific for cancer treatment. Structure-based virtual screening has made a great contribution to discover novel...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Artificial Intelligence in the Life Sciences |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667318523000028 |